Detalhe da pesquisa
1.
An immunologically relevant rodent model demonstrates safety of therapy using a tumour-specific IgE.
Allergy
; 73(12): 2328-2341, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29654623
2.
AllergoOncology - the impact of allergy in oncology: EAACI position paper.
Allergy
; 72(6): 866-887, 2017 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-28032353
3.
Epidemiological associations of allergy, IgE and cancer.
Clin Exp Allergy
; 43(10): 1110-23, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-24074329
4.
Harnessing engineered antibodies of the IgE class to combat malignancy: initial assessment of FcÉRI-mediated basophil activation by a tumour-specific IgE antibody to evaluate the risk of type I hypersensitivity.
Clin Exp Allergy
; 41(10): 1400-13, 2011 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-21569129
5.
PATRIOT: A phase I study to assess the tolerability, safety and biological effects of a specific ataxia telangiectasia and Rad3-related (ATR) inhibitor (AZD6738) as a single agent and in combination with palliative radiation therapy in patients with solid tumours.
Clin Transl Radiat Oncol
; 12: 16-20, 2018 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-30073210
6.
The p53-MDM2 interaction in a cancer-prone family, and the identification of a novel therapeutic target.
Acta Oncol
; 35(4): 429-34, 1996.
Artigo
em Inglês
| MEDLINE | ID: mdl-8695156
7.
Necrotic Peyer's patches in association with colonic ischaemia--unhelpful in selecting resection margin.
Eur J Surg
; 162(8): 667-8, 1996 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-8891628